All In Biotech

Drug Trial Radar · NCT00889330

Safety and Efficacy Study of a Eye Drop for Eye Allergy

Last checked: Nov 20, 2026Latest source record: Mar 6, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

60

Actual

Start

Apr 2009

Primary completion

May 2009

Sponsor

Lead sponsor
Vistakon PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Apr 28, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 10 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of an anti-allergy eyedrop.

Conditions

  • Allergic Conjunctivitis

Interventions

  • alcaftadineDrug

    0.25% Ophthalmic Solution, one drop in each eye at each of two visits.

  • PlaceboDrug

    Vehicle without active, one drop in each eye at each of two visits.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ocular Itching at Visit 3 (Day 0) at 7 Minutes Following Allergen Challenge, 16 Hours After Treatment Instillation.Time frame: Visit 3 (Day 0) 16 hours post-dose, at up to 7 minutes following Allergen Challenge
  2. Conjunctival Redness at Visit 3 (Day 0) at 20 Minutes Following Allergen Challenge, 16 Hours After Treatment InstillationTime frame: Visit 3 (Day 0) At 20 minutes following Allergen Challenge, 16 hours post-treatment
  3. Ocular Itching at Visit 4 (Day 14) at 7 Minutes Following Allergen Challenge, 15 Minutes Post- Treatment InstillationTime frame: Visit 4 (Day 14) up to 7 minutes following Allergen Challenge
  4. Conjunctival Redness at Visit 4 (Day 14) at 20 Minutes Following Allergen Challenge, 15 Minutes Post Treatment InstillationTime frame: Visit 4 (Day 14) At 20 minutes following Allergen Challenge

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Fairfield, Ohio

  • Site not named

    Mason, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.